Motl S - Search Results

1

Pharmacokinetic considerations in the treatment of CNS tumours.

Motl S, Zhuang Y, Waters CM, Stewart CF. Motl S, et al. Clin Pharmacokinet. 2006;45(9):871-903. doi: 10.2165/00003088-200645090-00002. Clin Pharmacokinet. 2006. PMID: 16928151 Review.

2

Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma.

Bashir H, Motl S, Metzger ML, Howard SC, Kaste S, Krasin MP, Hudson MM. Bashir H, et al. Among authors: motl s. J Pediatr Hematol Oncol. 2006 Jan;28(1):33-5. J Pediatr Hematol Oncol. 2006. PMID: 16394890

3

Bevacizumab in combination chemotherapy for colorectal and other cancers.

Motl S. Motl S. Am J Health Syst Pharm. 2005 May 15;62(10):1021-32. doi: 10.1093/ajhp/62.10.1021. Am J Health Syst Pharm. 2005. PMID: 15901587 Review.

4

Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.

Jahanzeb M, Sarna G, Hirsch R, Radice P, Koletsky A, Martinez M, Kruglyak E, Wolin E, Camacho E, Kronish L, Motl S. Jahanzeb M, et al. Among authors: motl s. Anticancer Res. 2004 Mar-Apr;24(2C):1239-42. Anticancer Res. 2004. PMID: 15154653 Free article. Clinical Trial.

5

Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review.

Motl SE, Baskin RC. Motl SE, et al. Pharmacotherapy. 2005 Aug;25(8):1151-5. doi: 10.1592/phco.2005.25.8.1151. Pharmacotherapy. 2005. PMID: 16207108 Review.

6

Technology evaluation: Canvaxin, John Wayne Cancer Institute/CancerVax.

Motl SE. Motl SE. Curr Opin Mol Ther. 2004 Feb;6(1):104-11. Curr Opin Mol Ther. 2004. PMID: 15011788 Clinical Trial.

7

Evaluation of accuracy of health studies reported in mass media.

Motl SE, Timpe EM, Eichner SF. Motl SE, et al. J Am Pharm Assoc (2003). 2005 Nov-Dec;45(6):720-5. doi: 10.1331/154434505774909670. J Am Pharm Assoc (2003). 2005. PMID: 16381419

8

Racial comparison of outcomes and costs for inpatient neutropenic patients: a multicenter evaluation.

Motl SE, Suda KJ, Kuth JC, Gladney TJ. Motl SE, et al. J Oncol Pract. 2006 Mar;2(2):53-6. doi: 10.1200/JOP.2006.2.2.53. J Oncol Pract. 2006. PMID: 20871717 Free PMC article.

9

Programs established by FDA to expedite patient access to medications.

Motl S, Miller SJ, Burns P. Motl S, et al. Am J Health Syst Pharm. 2003 Feb 15;60(4):339-45. doi: 10.1093/ajhp/60.4.339. Am J Health Syst Pharm. 2003. PMID: 12625215 No abstract available.

10

Proposal to improve MedWatch: decentralized, regional surveillance of adverse drug reactions.

Motl S, Timpe E, Eichner S. Motl S, et al. Am J Health Syst Pharm. 2004 Sep 1;61(17):1840-2. doi: 10.1093/ajhp/61.17.1840. Am J Health Syst Pharm. 2004. PMID: 15462254 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters